search
Back to results

Milk and Soured Milk (filmjölk) Intervention on Oxidative Stress and Inflammation

Primary Purpose

Oxidative Stress, Inflammation

Status
Completed
Phase
Not Applicable
Locations
Sweden
Study Type
Interventional
Intervention
Milk
Soured milk (filmjölk)
Sponsored by
Uppsala University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional basic science trial for Oxidative Stress

Eligibility Criteria

40 Years - 75 Years (Adult, Older Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria:

  • Tolerates both a low and a high intake of milk and soured milk
  • Agrees to comply with study protocol

Exclusion Criteria:

  • Inflammatory bowel disease
  • Major gastric tract operation
  • Pregnancy
  • Eating disorder

Sites / Locations

  • Forskningsmottagning bentäthet, Kirurgiska vetenskaper, Uppsala Universitet

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Experimental

Arm Label

Milk

Soured milk (filmjölk)

Arm Description

At least 500 ml of Swedish milk daily for three weeks (crossover). Intervention and crossover preceded by 3 weeks with max 50 ml of milk or soured milk (filmjölk) daily. Fat content of milk and soured milk should be the same: 0.5%, 1.5% or 3%.

At least 500 ml of Swedish soured milk (filmjölk) daily for three weeks (crossover). Intervention and crossover preceded by 3 weeks with max 50 ml of milk or soured milk (filmjölk) daily. Fat content of milk and soured milk should be the same: 0.5%, 1.5% or 3%.

Outcomes

Primary Outcome Measures

Change in oxidative stress marker
urinary 8-iso-prostaglandin F2 alpha (8-iso-PGF2alpha)
Change in oxidative stress marker
urinary 8-iso-prostaglandin F2 alpha (8-iso-PGF2alpha)

Secondary Outcome Measures

Change in interleukin-6 (IL-6)
Inflammation marker, measured in serum
Change in interleukin-6 (IL-6)
Inflammation marker, measured in serum
Change high sensitive C-reactive protein (hs-CRP)
Inflammation marker, measured in serum
Change high sensitive C-reactive protein (hs-CRP)
Inflammation marker, measured in serum
Change in 15-keto-dihydro-prostaglandin F2 alpha (15-keto-dihydro-PGF2alpha)
Inflammation marker, a major metabolite of prostaglandin F2alpha, measured in urine
Change in 15-keto-dihydro-prostaglandin F2 alpha (15-keto-dihydro-PGF2alpha)
Inflammation marker, a major metabolite of prostaglandin F2alpha, measured in urine

Full Information

First Posted
January 16, 2019
Last Updated
November 3, 2020
Sponsor
Uppsala University
Collaborators
Forte
search

1. Study Identification

Unique Protocol Identification Number
NCT03821116
Brief Title
Milk and Soured Milk (filmjölk) Intervention on Oxidative Stress and Inflammation
Official Title
Milk and Soured Milk (filmjölk) Intervention on Oxidative Stress and Inflammation: A Randomized Crossover Intervention Study
Study Type
Interventional

2. Study Status

Record Verification Date
November 2020
Overall Recruitment Status
Completed
Study Start Date
January 7, 2019 (Actual)
Primary Completion Date
June 9, 2020 (Actual)
Study Completion Date
June 9, 2020 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Uppsala University
Collaborators
Forte

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
This study evaluates a high intake of milk compared with a high intake of soured milk (Swedish filmjölk) on markers of oxidative stress and inflammation in a randomized crossover intervention study.
Detailed Description
A diet rich in antioxidants reduces oxidative stress and inflammation and could potentially improve health and lower the rate of hip fracture. Milk and dairy are also promoted as part of a healthy diet since they contain 18 of 22 essential nutrients including calcium, phosphorous, and vitamin D and have been suggested to be associated with lower risk of cardiovascular disease, especially stroke, type 2 diabetes, and cancer. Meta-analyses of milk and dairy on fracture and mortality risk in cohort studies are, however, inconclusive and show significant heterogeneity between studies. Small intakes may have beneficial effects in comparison to null intake whereas higher intakes may have other effects and non-linear relationships are rarely examined. Frequently, different milk products are considered as one entity in cohort studies. The investigators recently showed that different milk products might have differential effects on disease. A high long-term milk intake was associated with an increased risk of mortality (total, cardiovascular, and cancer mortality) and hip fracture, especially among women, whereas a high long-term intake of fermented milk (soured milk and yogurt or cheese) was associated with a lower risk of mortality and fracture among women. Similar results have been presented for total mortality (Northern Sweden) and humeral fractures (South-Eastern Australia). Intake of milk and fermented milk is of tradition high in Sweden. The prevalence of lactase persistence is high (around 95%). The range in milk intake from non- and low-consumers to high consumers makes Sweden an appropriate setting for epidemiological and interventional studies. A common potential mechanism for intake of fruits, vegetables, and different dairy products on risk of disease is their influence on inflammation and oxidative stress. Chronic low-grade inflammation and age-related increase of oxidative stress are suggested pathogenic mechanisms of premature ageing and many diseases including cardiovascular disease, cancer, accelerated bone loss (leading to osteoporosis), and age-related reduction of muscle strength and mass (sarcopenia) with potential impacts on risk of falling and fracture. The lower risk of fractures with a high intake of fermented milk products observed may be due to potential probiotic, antioxidative, and anti-inflammatory effects and effects on gut microbiota. A high intake of milk was not only associated with risk of mortality and fractures but also with increased concentrations of inflammation and oxidative stress markers. An inverse association was seen for intake of soured milk and yogurt [Michaëlsson, 2014]. Fermented milk products with probiotics have been shown to reduce the levels of inflammation markers, other studies have been small to show conclusive effects and results may also be dependent on the probiotic strain. A head-to-head comparison of the effect of regular milk and soured milk (or yogurt) on markers of inflammation and oxidative stress in a randomized intervention study is warranted. The randomized crossover intervention study will be performed among both men and women. The aim of the study is to examine the potentially different short-term effects of milk and sour milk on markers of oxidative stress and inflammation in a randomized cross-over trial. The research questions are: In a randomized cross-over trial, what is the effect of a daily intake of at least 500 ml of Swedish milk compared with an intake of at least 500 ml Swedish soured milk (filmjölk) during 3 weeks on markers of oxidative stress and inflammation? What are the effects of these milk products on a large number of proteins related with inflammation and ageing diseases, assessed with large-scale proteomic analysis? What are the effects of these milk products on metabolites involved in inflammation and ageing diseases using large-scale metabolomics analysis? What are the effects of these milk products on the gut microflora (microbiome)? Changes in proteomics, metabolomics and the gut microbiome are other pre-specified outcome measures but since they are exploratory in nature, we do not specify them under outcomes since it is not possible to exactly specify these outcome measures. Exploratory analyses will include whether effects are different between men and women, dependent on body composition (assessed with whole body dual X-ray absorptiometry, DXA) or long-term dietary intake (assessed by fatty acid composition in subcutaneous fat). Participants will be allowed to consume more than 500 ml of milk/filmjölk during the intervention periods and, if possible, a potential dose-response effect will be evaluated.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Oxidative Stress, Inflammation

7. Study Design

Primary Purpose
Basic Science
Study Phase
Not Applicable
Interventional Study Model
Crossover Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
84 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Milk
Arm Type
Experimental
Arm Description
At least 500 ml of Swedish milk daily for three weeks (crossover). Intervention and crossover preceded by 3 weeks with max 50 ml of milk or soured milk (filmjölk) daily. Fat content of milk and soured milk should be the same: 0.5%, 1.5% or 3%.
Arm Title
Soured milk (filmjölk)
Arm Type
Experimental
Arm Description
At least 500 ml of Swedish soured milk (filmjölk) daily for three weeks (crossover). Intervention and crossover preceded by 3 weeks with max 50 ml of milk or soured milk (filmjölk) daily. Fat content of milk and soured milk should be the same: 0.5%, 1.5% or 3%.
Intervention Type
Other
Intervention Name(s)
Milk
Intervention Description
Swedish milk from cow.
Intervention Type
Other
Intervention Name(s)
Soured milk (filmjölk)
Intervention Description
Swedish soured milk (from cow milk).
Primary Outcome Measure Information:
Title
Change in oxidative stress marker
Description
urinary 8-iso-prostaglandin F2 alpha (8-iso-PGF2alpha)
Time Frame
baseline and 3 weeks
Title
Change in oxidative stress marker
Description
urinary 8-iso-prostaglandin F2 alpha (8-iso-PGF2alpha)
Time Frame
6 weeks and 9 weeks
Secondary Outcome Measure Information:
Title
Change in interleukin-6 (IL-6)
Description
Inflammation marker, measured in serum
Time Frame
baseline and 3 weeks
Title
Change in interleukin-6 (IL-6)
Description
Inflammation marker, measured in serum
Time Frame
6 weeks and 9 weeks
Title
Change high sensitive C-reactive protein (hs-CRP)
Description
Inflammation marker, measured in serum
Time Frame
baseline and 3 weeks
Title
Change high sensitive C-reactive protein (hs-CRP)
Description
Inflammation marker, measured in serum
Time Frame
6 weeks and 9 weeks
Title
Change in 15-keto-dihydro-prostaglandin F2 alpha (15-keto-dihydro-PGF2alpha)
Description
Inflammation marker, a major metabolite of prostaglandin F2alpha, measured in urine
Time Frame
baseline and 3 weeks
Title
Change in 15-keto-dihydro-prostaglandin F2 alpha (15-keto-dihydro-PGF2alpha)
Description
Inflammation marker, a major metabolite of prostaglandin F2alpha, measured in urine
Time Frame
6 weeks and 9 weeks

10. Eligibility

Sex
All
Minimum Age & Unit of Time
40 Years
Maximum Age & Unit of Time
75 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: Tolerates both a low and a high intake of milk and soured milk Agrees to comply with study protocol Exclusion Criteria: Inflammatory bowel disease Major gastric tract operation Pregnancy Eating disorder
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Liisa Byberg, PhD
Organizational Affiliation
Department of Surgical Sciences, Uppsala University
Official's Role
Principal Investigator
Facility Information:
Facility Name
Forskningsmottagning bentäthet, Kirurgiska vetenskaper, Uppsala Universitet
City
Uppsala
ZIP/Postal Code
75185
Country
Sweden

12. IPD Sharing Statement

Plan to Share IPD
No
Citations:
PubMed Identifier
26378576
Citation
Larsson SC, Crippa A, Orsini N, Wolk A, Michaelsson K. Milk Consumption and Mortality from All Causes, Cardiovascular Disease, and Cancer: A Systematic Review and Meta-Analysis. Nutrients. 2015 Sep 11;7(9):7749-63. doi: 10.3390/nu7095363.
Results Reference
background
PubMed Identifier
25352269
Citation
Michaelsson K, Wolk A, Langenskiold S, Basu S, Warensjo Lemming E, Melhus H, Byberg L. Milk intake and risk of mortality and fractures in women and men: cohort studies. BMJ. 2014 Oct 28;349:g6015. doi: 10.1136/bmj.g6015.
Results Reference
background
PubMed Identifier
28490510
Citation
Tognon G, Nilsson LM, Shungin D, Lissner L, Jansson JH, Renstrom F, Wennberg M, Winkvist A, Johansson I. Nonfermented milk and other dairy products: associations with all-cause mortality. Am J Clin Nutr. 2017 Jun;105(6):1502-1511. doi: 10.3945/ajcn.116.140798. Epub 2017 May 10.
Results Reference
background
PubMed Identifier
26169198
Citation
Holloway KL, Bucki-Smith G, Morse AG, Brennan-Olsen SL, Kotowicz MA, Moloney DJ, Sanders KM, Korn S, Timney EN, Dobbins AG, Pasco JA. Humeral Fractures in South-Eastern Australia: Epidemiology and Risk Factors. Calcif Tissue Int. 2015 Nov;97(5):453-65. doi: 10.1007/s00223-015-0039-9. Epub 2015 Jul 14.
Results Reference
background

Learn more about this trial

Milk and Soured Milk (filmjölk) Intervention on Oxidative Stress and Inflammation

We'll reach out to this number within 24 hrs